Aquestive Therapeutics, Inc. ($AQST)
Filing Information
| Accession Number | 0001214659-26-003145 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 11, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
170,102
Total Value
$381,845.65
P&L
+141.2% (+$302,900.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Mar 9, 2026 | Grant/Award | 80,000 | $0.00 | $0.00 | 482,981 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Mar 10, 2026 | Sale | 40,102 | $4.17 | $167,345.65 | 442,879 | Direct | โ | View Details | |
Chief Legal Officer | Non-Qualified Stock Option (right to buy) | Derivative | Mar 9, 2026 | Grant/Award | 50,000 | $4.29 | $214,500.00 | 50,000 | Direct | โ | View Details |